D’Avila et al. reported that an AMH level of <3.32 ng/mL and AFC of <13 follicles were correlated with a significantly higher risk of amenorrhea or oligomenorrhea development after cyclophosphamide treatment [31]. Here, AMH is linked to amenorrhea.